Pre-Open Stock Movers 05/17: (RRGB) (JACK) (TGT) Higher; (BEBE) (PLUG) (XLRN) Lower (more...) May 17, 2017 09:32AM
Roth Capital Reiterates Buy on Concert Pharma (CNCE) Following a Milestone Achievement Oct 8, 2015 10:34AM
Roth Capital Raises Price Target on Concert Pharma (CNCE) Following CTP-656 Data Sep 22, 2015 01:22PM
Roth Remains Positive on Concert Pharma (CNCE) Amid Upcoming AVP-786 Phase 3s (AVNR) May 18, 2015 10:10AM
Roth Boosts PT on Concert Pharma (CNCE) to $22 Following; Deuterium Platform, Partnerships Will Bolster Gains May 8, 2015 03:08PM


Apr 1, 2015 08:51AM Roth Remains Positive on Concert Pharma (CNCE) Following Equity Offering; Affirms 'Buy' Rating
Mar 24, 2015 04:01PM Concert Pharmaceuticals Announces Completion of Public Offering
Mar 19, 2015 09:24AM Concert Pharma (CNCE) Prices 3.3M Common Stock Offering at $15.15/Share
Mar 19, 2015 09:00AM Concert Pharmaceuticals Announces Pricing of Public Offering
Nov 12, 2014 11:37AM Roth Trims Price Target on Concert (CNCE) to $21; CTP-354 Phase II Delayed on Toxicity Signal
Sep 17, 2014 09:30AM Roth Comments on Concert's (CNCE) Initiation of CTP-730 Phase 1
Sep 15, 2014 02:09PM Roth Keeps Concert Pharma (CNCE) at 'Buy'; AVP-923 Phase 2 Data is Encouraging (AVNR)
Aug 12, 2014 03:23PM Roth Keeps Concert Pharma (CNCE) at Buy; Making Good Progress with Clinical Programs
Jul 16, 2014 12:13PM Streetinsider.com's Hot Lunchtime Reads 07/16: (AAPL) (MCP) (MNGA) (YHOO)
Jul 16, 2014 10:54AM Roth Capital Encouraged by Removal of CTP-354 Clinical Hold; Has Concert Pharma (CNCE) at 'Buy'
Jul 8, 2014 12:07PM Streetinsider.com's Hot Lunchtime Reads 07/08: (PETM) (AAPL) (CNCE) (MSFT)
Jul 8, 2014 10:30AM Roth Capital Keeps Concert Pharma (CNCE) at 'Buy'; SPA Filing is Sign of Confidence in CTP-499
Mar 19, 2014 09:14AM Roth Capital Starts Concert Pharmaceuticals (CNCE) at Buy
Feb 13, 2014 10:55AM Concert Pharmaceuticals (CNCE) IPO Jumps Higher
Jan 14, 2014 06:55AM Concert Pharmaceuticals (CNCE) Files $74.75M IPO